Valisure is proud to announce its membership in the End Drug Shortages Alliance (EDSA), a coalition of diverse healthcare stakeholders working to address one of the industry’s most persistent challenges: drug shortages that compromise patient care.

Founded in 2021, the Alliance brings together providers, group purchasing organizations, manufacturers, distributors, and industry thought leaders to promote transparency, collaboration, and quality-focused solutions. Through this partnership, Valisure will contribute its unique expertise in independent quality assurance and chemical analysis to help improve medication access and strengthen the resilience of the pharmaceutical supply chain.

“Drug shortages are a symptom of deeper systemic issues in quality and transparency. We’re proud to collaborate with others committed to long-term, data-driven solutions,” said David Light, Co-Founder & President of Valisure.

Learn more at www.EndDrugShortages.com

‍

Valisure is proud to announce its membership in the End Drug Shortages Alliance (EDSA), a coalition of diverse healthcare stakeholders working to address one of the industry’s most persistent challenges: drug shortages that compromise patient care.

Founded in 2021, the Alliance brings together providers, group purchasing organizations, manufacturers, distributors, and industry thought leaders to promote transparency, collaboration, and quality-focused solutions. Through this partnership, Valisure will contribute its unique expertise in independent quality assurance and chemical analysis to help improve medication access and strengthen the resilience of the pharmaceutical supply chain.

“Drug shortages are a symptom of deeper systemic issues in quality and transparency. We’re proud to collaborate with others committed to long-term, data-driven solutions,” said David Light, Co-Founder & President of Valisure.

Learn more at www.EndDrugShortages.com

‍